AAPL338.98+2.85 (+0.85%) ▲|ABBV264.48+0.52 (+0.20%) ▲|ABT102.98+0.37 (+0.36%) ▲|ACN186.11+4.82 (+2.66%) ▲|ADBE249.52+0.60 (+0.24%) ▲|AMAT464.24+19.67 (+4.42%) ▲|AMD615.52+55.70 (+9.95%) ▲|AMGN393.16+7.51 (+1.95%) ▲|AMT174.60+0.62 (+0.36%) ▲|AMZN258.45+4.74 (+1.87%) ▲|AVGO362.66+5.70 (+1.60%) ▲|AXP313.59+2.03 (+0.65%) ▲|BA201.15+2.95 (+1.49%) ▲|BAC57.96+0.23 (+0.40%) ▲|BKNG168.52+0.62 (+0.37%) ▲|BLK1,090.27+20.49 (+1.92%) ▲|BMY62.62-0.44 (-0.70%) ▼|BNY153.89+0.10 (+0.07%) ▲|BRK-B502.01-7.76 (-1.52%) ▼|C135.05+3.28 (+2.49%) ▲|CAT816.50+7.51 (+0.93%) ▲|CL86.26-1.21 (-1.38%) ▼|CMCSA22.93+0.19 (+0.84%) ▲|COF204.92+2.49 (+1.23%) ▲|COP127.53-4.30 (-3.26%) ▼|COST898.48+3.17 (+0.35%) ▲|CRM236.42-1.50 (-0.63%) ▼|CSCO111.46+1.95 (+1.78%) ▲|CVS87.60-1.24 (-1.40%) ▼|CVX203.67-5.84 (-2.79%) ▼|DE684.73+0.74 (+0.11%) ▲|DHR215.84+4.03 (+1.90%) ▲|DIS104.23+1.56 (+1.52%) ▲|DUK116.74-0.79 (-0.67%) ▼|EMR151.72+1.80 (+1.20%) ▲|FDX295.79-7.86 (-2.59%) ▼|GD353.90+0.85 (+0.24%) ▲|GE319.01+4.74 (+1.51%) ▲|GEV946.22+5.89 (+0.63%) ▲|GILD150.56+0.45 (+0.30%) ▲|GM83.95+1.75 (+2.13%) ▲|GOOG350.87+6.46 (+1.88%) ▲|GOOGL354.97+5.43 (+1.55%) ▲|GS959.39+17.39 (+1.85%) ▲|HD297.20-2.78 (-0.93%) ▼|HON206.48+0.02 (+0.01%) ▲|IBM231.93+2.38 (+1.04%) ▲|INTC121.78+13.18 (+12.14%) ▲|INTU304.12+0.93 (+0.31%) ▲|ISRG401.65+8.32 (+2.12%) ▲|JNJ269.47-0.52 (-0.19%) ▼|JPM352.04+2.37 (+0.68%) ▲|KO87.12-1.13 (-1.28%) ▼|LIN457.50-2.90 (-0.63%) ▼|LLY1,164.89+11.96 (+1.04%) ▲|LMT535.40+2.02 (+0.38%) ▲|LOW190.98-1.51 (-0.78%) ▼|LRCX302.28+14.17 (+4.92%) ▲|MA567.65+2.41 (+0.43%) ▲|MCD247.88-0.36 (-0.15%) ▼|MDLZ60.17-0.68 (-1.12%) ▼|MDT91.75-0.38 (-0.41%) ▼|META741.25+76.02 (+11.43%) ▲|MMM164.97-0.92 (-0.55%) ▼|MO68.53-0.99 (-1.42%) ▼|MRK149.50+2.63 (+1.79%) ▲|MS206.12+3.54 (+1.75%) ▲|MSFT501.61+7.83 (+1.59%) ▲|MU1,043.96+28.16 (+2.77%) ▲|NEE79.63-0.84 (-1.04%) ▼|NFLX73.36+1.57 (+2.19%) ▲|NKE36.10+0.59 (+1.66%) ▲|NOW137.68+2.21 (+1.63%) ▲|NVDA227.38+5.11 (+2.30%) ▲|ORCL148.56+0.95 (+0.64%) ▲|PEP129.59-0.16 (-0.12%) ▼|PFE27.74+0.08 (+0.29%) ▲|PG146.08-0.31 (-0.21%) ▼|PLTR183.09+5.45 (+3.07%) ▲|PM187.48-1.14 (-0.60%) ▼|QCOM194.23+16.51 (+9.29%) ▲|RTX194.34+0.34 (+0.18%) ▲|SBUX94.90-0.93 (-0.97%) ▼|SCHW106.88+1.63 (+1.55%) ▲|SO85.46-0.06 (-0.07%) ▼|SPG204.98-0.34 (-0.17%) ▼|T25.45+0.05 (+0.20%) ▲|TMO658.76+7.31 (+1.12%) ▲|TMUS165.27-2.91 (-1.73%) ▼|TSLA375.30+11.03 (+3.03%) ▲|TXN270.87+4.23 (+1.59%) ▲|UBER70.84+0.34 (+0.48%) ▲|UNH377.56+0.66 (+0.18%) ▲|UNP269.63-9.74 (-3.49%) ▼|UPS94.75-4.31 (-4.35%) ▼|USB60.44+0.38 (+0.63%) ▲|V369.95+1.66 (+0.45%) ▲|VZ47.68-0.41 (-0.85%) ▼|WFC86.54+0.42 (+0.49%) ▲|WMT107.44+0.71 (+0.67%) ▲|XOM158.30-5.24 (-3.20%) ▼|AAPL338.98+2.85 (+0.85%) ▲|ABBV264.48+0.52 (+0.20%) ▲|ABT102.98+0.37 (+0.36%) ▲|ACN186.11+4.82 (+2.66%) ▲|ADBE249.52+0.60 (+0.24%) ▲|AMAT464.24+19.67 (+4.42%) ▲|AMD615.52+55.70 (+9.95%) ▲|AMGN393.16+7.51 (+1.95%) ▲|AMT174.60+0.62 (+0.36%) ▲|AMZN258.45+4.74 (+1.87%) ▲|AVGO362.66+5.70 (+1.60%) ▲|AXP313.59+2.03 (+0.65%) ▲|BA201.15+2.95 (+1.49%) ▲|BAC57.96+0.23 (+0.40%) ▲|BKNG168.52+0.62 (+0.37%) ▲|BLK1,090.27+20.49 (+1.92%) ▲|BMY62.62-0.44 (-0.70%) ▼|BNY153.89+0.10 (+0.07%) ▲|BRK-B502.01-7.76 (-1.52%) ▼|C135.05+3.28 (+2.49%) ▲|CAT816.50+7.51 (+0.93%) ▲|CL86.26-1.21 (-1.38%) ▼|CMCSA22.93+0.19 (+0.84%) ▲|COF204.92+2.49 (+1.23%) ▲|COP127.53-4.30 (-3.26%) ▼|COST898.48+3.17 (+0.35%) ▲|CRM236.42-1.50 (-0.63%) ▼|CSCO111.46+1.95 (+1.78%) ▲|CVS87.60-1.24 (-1.40%) ▼|CVX203.67-5.84 (-2.79%) ▼|DE684.73+0.74 (+0.11%) ▲|DHR215.84+4.03 (+1.90%) ▲|DIS104.23+1.56 (+1.52%) ▲|DUK116.74-0.79 (-0.67%) ▼|EMR151.72+1.80 (+1.20%) ▲|FDX295.79-7.86 (-2.59%) ▼|GD353.90+0.85 (+0.24%) ▲|GE319.01+4.74 (+1.51%) ▲|GEV946.22+5.89 (+0.63%) ▲|GILD150.56+0.45 (+0.30%) ▲|GM83.95+1.75 (+2.13%) ▲|GOOG350.87+6.46 (+1.88%) ▲|GOOGL354.97+5.43 (+1.55%) ▲|GS959.39+17.39 (+1.85%) ▲|HD297.20-2.78 (-0.93%) ▼|HON206.48+0.02 (+0.01%) ▲|IBM231.93+2.38 (+1.04%) ▲|INTC121.78+13.18 (+12.14%) ▲|INTU304.12+0.93 (+0.31%) ▲|ISRG401.65+8.32 (+2.12%) ▲|JNJ269.47-0.52 (-0.19%) ▼|JPM352.04+2.37 (+0.68%) ▲|KO87.12-1.13 (-1.28%) ▼|LIN457.50-2.90 (-0.63%) ▼|LLY1,164.89+11.96 (+1.04%) ▲|LMT535.40+2.02 (+0.38%) ▲|LOW190.98-1.51 (-0.78%) ▼|LRCX302.28+14.17 (+4.92%) ▲|MA567.65+2.41 (+0.43%) ▲|MCD247.88-0.36 (-0.15%) ▼|MDLZ60.17-0.68 (-1.12%) ▼|MDT91.75-0.38 (-0.41%) ▼|META741.25+76.02 (+11.43%) ▲|MMM164.97-0.92 (-0.55%) ▼|MO68.53-0.99 (-1.42%) ▼|MRK149.50+2.63 (+1.79%) ▲|MS206.12+3.54 (+1.75%) ▲|MSFT501.61+7.83 (+1.59%) ▲|MU1,043.96+28.16 (+2.77%) ▲|NEE79.63-0.84 (-1.04%) ▼|NFLX73.36+1.57 (+2.19%) ▲|NKE36.10+0.59 (+1.66%) ▲|NOW137.68+2.21 (+1.63%) ▲|NVDA227.38+5.11 (+2.30%) ▲|ORCL148.56+0.95 (+0.64%) ▲|PEP129.59-0.16 (-0.12%) ▼|PFE27.74+0.08 (+0.29%) ▲|PG146.08-0.31 (-0.21%) ▼|PLTR183.09+5.45 (+3.07%) ▲|PM187.48-1.14 (-0.60%) ▼|QCOM194.23+16.51 (+9.29%) ▲|RTX194.34+0.34 (+0.18%) ▲|SBUX94.90-0.93 (-0.97%) ▼|SCHW106.88+1.63 (+1.55%) ▲|SO85.46-0.06 (-0.07%) ▼|SPG204.98-0.34 (-0.17%) ▼|T25.45+0.05 (+0.20%) ▲|TMO658.76+7.31 (+1.12%) ▲|TMUS165.27-2.91 (-1.73%) ▼|TSLA375.30+11.03 (+3.03%) ▲|TXN270.87+4.23 (+1.59%) ▲|UBER70.84+0.34 (+0.48%) ▲|UNH377.56+0.66 (+0.18%) ▲|UNP269.63-9.74 (-3.49%) ▼|UPS94.75-4.31 (-4.35%) ▼|USB60.44+0.38 (+0.63%) ▲|V369.95+1.66 (+0.45%) ▲|VZ47.68-0.41 (-0.85%) ▼|WFC86.54+0.42 (+0.49%) ▲|WMT107.44+0.71 (+0.67%) ▲|XOM158.30-5.24 (-3.20%) ▼|
15.7 C
New York
Tuesday, September 22, 2026

Tag: 6

Scatec ASA: Employee Share Purchase Programme 2025

Oslo, 16 June 2025: Scatec ASA (“The Company”) is continuing its Employee Share Purchase Programme established in 2019. The participants are offered to purchase shares with a subscription value of between NOK 10,413 and NOK 104,128. Employees are offered a price reduction of 25 percent of the subscription value in exchange for the shares being subject to a two-year lock-up period.

The 4th Edition of AMSC Malaysia Returns in 2025: Uniting Global Leaders in Aesthetic Medicine, Dermatology, and Surgery

KUALA LUMPUR, Malaysia, June 16, 2025 /PRNewswire/ -- The Aesthetic Medicine & Surgery Conference & Exhibition (AMSC) returns for its highly anticipated fourth edition...

Global Times: Practitioners’ Insights: Urban-rural bus Route 101 – a vivid practice of ‘following a good blueprint through to the end’

BEIJING, June 15, 2025 /PRNewswire/ -- In the early morning, the lights of the Daxin Road bus hub in downtown Jiaxing cut through the mist....

Relax, Recharge, Repeat: Agoda Unveils Asia’s Top Wellness Escapes

SINGAPORE, June 16, 2025 /PRNewswire/ -- Digital travel platform Agoda has curated a list of Asia's most rejuvenating wellness destinations, perfect for travelers seeking holistic,...

Subgroup Analysis of Cadonilimab as First-Line Therapy for Advanced Cervical Cancer Reported in an Oral Presentation at ASCO 2025

HONG KONG, June 15, 2025 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company")  presented the subgroup analysis data from the Phase III COMPASSION-16...

Netcore Cloud Strengthens Presence in Indonesia to Empower BFSI, Retail, and Ecommerce Brands

With 100+ customers across Indonesia, Netcore deepens its Indonesia presence through local teams and a new data center to empower local brands JAKARTA, Indonesia, June...

Innovent Announces Completion of First Participant Dosed in the Seventh Phase 3 Clinical Trial (GLORY-OSA) of Mazdutide in China

SAN FRANCISCO and SUZHOU, China, June 15, 2025 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes...

EHA 2025 | Multiple Studies Report Encouraging Data of Olverembatinib in Ph+ ALL

ROCKVILLE, Md. and SUZHOU, China, June 15, 2025 (GLOBE NEWSWIRE) -- Ascentage Pharma (NASDAQ: AAPG; HKEX: 6855), a global biopharmaceutical company dedicated to addressing unmet medical needs in cancers, announced that results from 13 studies of its core assets, including the novel drug olverembatinib (HQP1351) and the investigational EED inhibitor APG-5918, have been reported at the 2025 European Hematology Association (EHA) Annual Congress.

Celltrion announces U.S. FDA approval of additional presentation of STEQEYMA® (ustekinumab-stba), expanding dosing options for pediatric patients

Approval of 45mg/0.5mL solution in a single-dose vial for subcutaneous injection expands dosing flexibility for pediatric patients with plaque psoriasis (PsO) or psoriatic arthritis...

Début de la campagne internationale « Pay As You Like »

VARSOVIE, Pologne, 16 juin 2025 (GLOBE NEWSWIRE) -- La campagne Pay As You Like ciblée sur la promotion des moyens de paiement modernes est officiellement lancée. Il s’agit d’une nouvelle édition de son homologue We Did It In Poland, portée par la fondation WłączeniPlus. L’an dernier, les opérations dématérialisées comptaient pour 69 % des transactions commerciales en Pologne. La campagne Pay As You Like vise à montrer la grande convivialité des moyens de paiement dématérialisés dans ce pays, où des entrepreneurs et des millions de particuliers y ont recours quotidiennement.

Start der internationalen Kampagne „Pay As You Like“

WARSCHAU, Polen, June 16, 2025 (GLOBE NEWSWIRE) -- Die Kampagne „Pay As You Like“, die moderne Zahlungsmethoden fördert, ist gestartet worden – als weitere Ausgabe von „We Did It In Poland“ der WłączeniPlus-Stiftung. Im vergangenen Jahr wurden in Polen 69 % aller Einzelhandelszahlungen bargeldlos durchgeführt. „Pay As You Like“ soll zeigen, wie benutzerfreundlich das bargeldlose Zahlungssystem in Polen ist, das täglich von Millionen Verbraucherinnen und Verbrauchern sowie von Unternehmerinnen und Unternehmern genutzt wird.

Zenobē and Brampton lead CA$4 billion initiative to electrify transit bus fleet in landmark UK-Canada collaboration

CA$4B to fund one of North America's largest single zero-emission bus initiatives Initiative expected to support 5,000 direct and indirect jobs across U.K. and...

1000 Miglia 2025 蓄势待发

世界最美赛事重返意大利公路
世界最美赛事重返意大利公路

2025 年 1000 Miglia 一千英里耐力賽蓄勢待發

全球最美賽事重返意大利道路
全球最美賽事重返意大利道路

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTags6